Exact Mass: 321.2151

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AD - Benzomorphan derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

Phenazocine

1,13-dimethyl-10-(2-phenylethyl)-10-azatricyclo[7.3.1.0^{2,7}]trideca-2(7),3,5-trien-4-ol

Rimcazole

9-[3-(3,5-dimethylpiperazin-1-yl)propyl]-9H-carbazole

9-[3-(3,5-dimethyl-1-piperazinyl)propyl]carbazole

N-Feruloylspermidine

Leelamine HCl

(1R,4aS,10aR)-1,2,3,4,4a,9,10,10a-Octahydro-1-,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenemethanamine hydrochloride

C20H32ClN (321.2223)

Leelamine hydrochloride is a tricyclic diterpene molecule that is extracted from the bark of pine trees[1]. Leelamine hydrochloride is a cannabinoid receptor type 1 (CB1) agonist and a inhibitor of SREBP1-regulated fatty acid/lipid synthesis in prostate cancer cells that is not affected by androgen receptor status. Leelamine hydrochloride suppresses transcriptional activity of androgen receptor, which is known to regulate fatty acid synthesis[2,3]. Leelamine hydrochloride is a tricyclic diterpene molecule that is extracted from the bark of pine trees[1]. Leelamine hydrochloride is a cannabinoid receptor type 1 (CB1) agonist and a inhibitor of SREBP1-regulated fatty acid/lipid synthesis in prostate cancer cells that is not affected by androgen receptor status. Leelamine hydrochloride suppresses transcriptional activity of androgen receptor, which is known to regulate fatty acid synthesis[2,3].

Rimcazole

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D020011 - Protective Agents

N-(3S,4S-methylene-decanoyl) histidine

N-(3S,4S-methylene-decanoyl)-histidine

Amino-PEG4-Boc

C15H31NO6 (321.2151)

Ethybenztropine

N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AC - Ethers of tropine or tropine derivatives C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent

R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist

2-(1,1-diethoxyethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

C17H28BNO4 (321.2111)

4-(diisopropylamino)-2-phenyl-2-(2-pyridyl)-butyronitrile

N-Octanoyl-N-methyl-D-glucamine

C15H31NO6 (321.2151)

4-(1-Pyrazin-2-yl-ethoxyMethyl)-piperidine-1-carboxylic acid tert-butyl ester

(+)-Phenazocine

monacolin L carboxylate

C19H29O4- (321.2066)

A hydroxy monocarboxylic acid anion that is the conjugate base of monacolin L acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

17-Hydroxy-1-oxo-2,3-secoandrostan-3-oate

C19H29O4- (321.2066)

(5S,6R,9R)-14-amino-5-methoxy-3,6,9-trimethyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-2-one

2-Hexyl-5-(7-carboxyheptyl)resorcinol

C19H29O4- (321.2066)

Bicarphene hydrochloride

Phenazocine, (-)-